A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Conditions: Lymphoma, Non-Hodgkin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Lymphoma, B-Cell Intervention: Drug: ALETA-001 Sponsors: Cancer Research UK; Aleta BioTherapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials